CPG
WST icon

Custom Portfolio Group’s West Pharmaceutical WST Stock Holding History

Custom Portfolio Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$49.4K Hold
150
– – 0.04% 107
2024
Q1 		$59.4K Hold
150
– – 0.05% 100
2023
Q4 		$52.8K Buy
+150
New +$53.1K 0.05% 94

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Custom Portfolio Group's WST Position: Q2 2024 in Review

Custom Portfolio Group held its West Pharmaceutical (WST) position steady in Q2 2024 at 150 shares worth $49.4K. The position accounts for 0.04% of the portfolio, ranked #107.

Custom Portfolio Group first reported a position in WST in Q4 2023 and has held it in 3 quarters since. The position peaked at $59.4K in Q1 2024. 777 funds tracked by Wall St. Rank hold WST as of Q2 2024.

  • Custom Portfolio Group held 150 shares of West Pharmaceutical worth $49.4K as of Q2 2024.
  • Custom Portfolio Group left its West Pharmaceutical share count unchanged in Q2 2024.
  • West Pharmaceutical made up 0.04% of Custom Portfolio Group's portfolio in Q2 2024, its #107 holding.
  • Custom Portfolio Group first reported a position in West Pharmaceutical in Q4 2023 and has held it in 3 quarters since.
  • Custom Portfolio Group's West Pharmaceutical position peaked at $59.4K in Q1 2024.
  • 777 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.

Based on Custom Portfolio Group's 13F filing for Q2 2024, filed 27 Aug 2024.